China (Mainland)
Glipizide(CEP) GMP standard: BP CP USP EP CAS NO.29094-61-9
- Min.Order: 0 Metric Ton
- Payment Terms: L/C,T/T
- Product Details
Keywords
- Glipizide
- 29094-61-9
- anti-diabetic
Quick Details
- ProName: Glipizide(CEP) GMP standard: BP ...
- CasNo: 29094-61-9
- Molecular Formula: C21H27N5O4S
- Appearance: White crystalline powder
- Application: Glipizide Tablets anti-diabetic drugs
- ProductionCapacity: Metric Ton/Day
- Purity: 100.3%
- LimitNum: 0 Metric Ton
Superiority
We have cGMP and CEP Certificate of Glipizide ,with DMF ,standards: BP / CP / USP /EP
Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.
Disha Pharmaceutical Group are Chinese producer of pharmaceutical intermediates & APIs& finish preparations with high quality and reliable service.covering 4 categories including anti-diabetic drugs,
anti-hypertension drug, digestive system drugs and antisepsis and anti- inflammation drugs.
Details
We have cGMP and CEP Certificate of Glipizide ,with DMF ,standards: BP / CP / USP /EP
Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.
Disha Pharmaceutical Group are Chinese producer of pharmaceutical intermediates & APIs& finish preparations with high quality and reliable service.covering 4 categories including anti-diabetic drugs,
anti-hypertension drug, digestive system drugs and antisepsis